327 related articles for article (PubMed ID: 19591816)
1. The significance of the hemoglobin A(2) value in screening for hemoglobinopathies.
Giambona A; Passarello C; Renda D; Maggio A
Clin Biochem; 2009 Dec; 42(18):1786-96. PubMed ID: 19591816
[TBL] [Abstract][Full Text] [Related]
2. Carrier screening for thalassemia and hemoglobinopathies in Canada.
Langlois S; Ford JC; Chitayat D; ;
J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
[TBL] [Abstract][Full Text] [Related]
3. The role of haemoglobin A(2) testing in the diagnosis of thalassaemias and related haemoglobinopathies.
Mosca A; Paleari R; Ivaldi G; Galanello R; Giordano PC
J Clin Pathol; 2009 Jan; 62(1):13-7. PubMed ID: 19103851
[TBL] [Abstract][Full Text] [Related]
4. [Screening for alpha-thalassemia using DNA analysis].
Beris P; Grossiord D; Hochmann A; Zhu L; Miescher PA
Schweiz Med Wochenschr; 1988 Oct; 118(42):1538-41. PubMed ID: 3201208
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnosis of inherited disorders: lessons from hemoglobinopathies.
Patrinos GP; Kollia P; Papadakis MN
Hum Mutat; 2005 Nov; 26(5):399-412. PubMed ID: 16138310
[TBL] [Abstract][Full Text] [Related]
6. Silent thalassemias: genotypes and phenotypes.
Bianco I; Cappabianca MP; Foglietta E; Lerone M; Deidda G; Morlupi L; Grisanti P; Ponzini D; Rinaldi S; Graziani B
Haematologica; 1997; 82(3):269-80. PubMed ID: 9234571
[TBL] [Abstract][Full Text] [Related]
7. A brief review on newborn screening methods for hemoglobinopathies and preliminary results selecting beta thalassemia carriers at birth by quantitative estimation of the HbA fraction.
Mantikou E; Arkesteijn SG; Beckhoven van JM; Kerkhoffs JL; Harteveld CL; Giordano PC
Clin Biochem; 2009 Dec; 42(18):1780-5. PubMed ID: 19733162
[TBL] [Abstract][Full Text] [Related]
8. Screening for the carriers of thalassemias and abnormal hemoglobins at the community level.
Winichagoon P; Thitivichianlert A; Lebnak T; Piankijagum A; Fucharoen S
Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 2():145-50. PubMed ID: 12755285
[TBL] [Abstract][Full Text] [Related]
9. Newborn screening for hemoglobin disorders.
Hoppe CC
Hemoglobin; 2011; 35(5-6):556-64. PubMed ID: 21910601
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis and hematologic characterization of deltabeta-thalassemia and hereditary persistence of fetal hemoglobin in Thailand.
Panyasai S; Fucharoen S; Surapot S; Fucharoen G; Sanchaisuriya K
Haematologica; 2004 Jul; 89(7):777-81. PubMed ID: 15257928
[TBL] [Abstract][Full Text] [Related]
12. Standardization on laboratory diagnosis of thalassemia and abnormal hemoglobin.
Fucharoen S; Winichagoon P; Piankijagum A
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():90-8. PubMed ID: 10926267
[TBL] [Abstract][Full Text] [Related]
13. Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and HbA2.
Rodriguez-Capote K; Higgins TN
Clin Biochem; 2015 Jul; 48(10-11):698-702. PubMed ID: 25869492
[TBL] [Abstract][Full Text] [Related]
14. Carrier screening and prenatal diagnosis of hemoglobinopathies. A study of indigenous and immigrant couples in northern Greece, over the last 5 years.
Theodoridou S; Alemayehou M; Prappas N; Karakasidou O; Aletra V; Plata E; Tsaftaridis P; Karababa P; Boussiou M; Sinopoulou K; Hatzi A; Voskaridou E; Loutradi A; Manitsa A
Hemoglobin; 2008; 32(5):434-9. PubMed ID: 18932067
[TBL] [Abstract][Full Text] [Related]
15. [Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data].
Fattoum S
Tunis Med; 2006 Nov; 84(11):687-96. PubMed ID: 17294892
[TBL] [Abstract][Full Text] [Related]
16. The relevance of hemoglobin F measurement in the diagnosis of thalassemias and related hemoglobinopathies.
Mosca A; Paleari R; Leone D; Ivaldi G
Clin Biochem; 2009 Dec; 42(18):1797-801. PubMed ID: 19580798
[TBL] [Abstract][Full Text] [Related]
17. Validation of osmotic fragility test and dichlorophenol indophenol precipitation test for screening of thalassemia and Hb E.
Sangkitporn S; Sangkitporn S; Sangnoi A; Supangwiput O; Tanphaichitr VS
Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1538-42. PubMed ID: 16610659
[TBL] [Abstract][Full Text] [Related]
18. [A community-based genetic screening of large-scale population and prenatal diagnosis for alpha and beta thalassemia in Zhuhai city of Guangdong province].
Zhou YQ; Mo QH; Lu JH; Li LY; Liang X; Jia SQ; Xiao GF; Zhou WJ; Xiao QZ; Xu XM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):256-61. PubMed ID: 18543211
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of hemoglobinopathies in the state of Orissa, India: a ten years cohort study.
Balgir RS
J Assoc Physicians India; 2005 Dec; 53():1021-6. PubMed ID: 16572956
[TBL] [Abstract][Full Text] [Related]
20. The validation of an automated liquid chromatography system for the diagnosis of thalassemias and hemoglobinopathies.
Sangkitporn S; Pung-amritt P; Sangkitporn SK; Sangnoi A; Tanphaichitr VS
Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):862-8. PubMed ID: 12757240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
